These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31959703)

  • 1. Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.
    Couto N; Al-Majdoub ZM; Gibson S; Davies PJ; Achour B; Harwood MD; Carlson G; Barber J; Rostami-Hodjegan A; Warhurst G
    Drug Metab Dispos; 2020 Apr; 48(4):245-254. PubMed ID: 31959703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
    Achour B; Russell MR; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
    Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
    Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
    Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.
    Kim S; Choi WG; Kwon M; Lee S; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31430908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).
    Albassam AA; Markowitz JS
    Planta Med; 2017 Apr; 83(6):496-508. PubMed ID: 28118673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes.
    Takahashi RH; Forrest WF; Smith AD; Badee J; Qiu N; Schmidt S; Collier AC; Parrott N; Fowler S
    Drug Metab Dispos; 2021 Sep; 49(9):760-769. PubMed ID: 34187837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Intra-Subject Analysis of Gene Expression and Protein Abundance of Major and Minor Drug Metabolizing Enzymes in Healthy Human Jejunum and Liver.
    Wenzel C; Lapczuk-Romanska J; Malinowski D; Ostrowski M; Drozdzik M; Oswald S
    Clin Pharmacol Ther; 2024 Feb; 115(2):221-230. PubMed ID: 37739780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
    Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine.
    Zhang H; Wolford C; Basit A; Li AP; Fan PW; Murray BP; Takahashi RH; Khojasteh SC; Smith BJ; Thummel KE; Prasad B
    Drug Metab Dispos; 2020 Jul; 48(7):528-536. PubMed ID: 32350063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters.
    Bleasby K; Houle R; Hafey M; Lin M; Guo J; Lu B; Sanchez RI; Fillgrove KL
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis.
    Vasilogianni AM; Al-Majdoub ZM; Achour B; Annie Peters S; Barber J; Rostami-Hodjegan A
    Clin Pharmacol Ther; 2022 Sep; 112(3):699-710. PubMed ID: 35510337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.
    Harwood MD; Achour B; Russell MR; Carlson GL; Warhurst G; Rostami-Hodjegan A
    J Pharm Biomed Anal; 2015 Jun; 110():27-33. PubMed ID: 25796981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.
    Heikkinen AT; Friedlein A; Matondo M; Hatley OJ; Petsalo A; Juvonen R; Galetin A; Rostami-Hodjegan A; Aebersold R; Lamerz J; Dunkley T; Cutler P; Parrott N
    Pharm Res; 2015 Jan; 32(1):74-90. PubMed ID: 25033762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.
    Wenzel C; Drozdzik M; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122891. PubMed ID: 34390906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.
    Li AP; Ho MD; Alam N; Mitchell W; Wong S; Yan Z; Kenny JR; E C A Hop C
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00645. PubMed ID: 32851819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of the diterpenoid 14-deoxy-11,12-didehydroandrographolide in rats and up-regulation of hepatic drug-metabolizing enzyme and drug transporter expression.
    Yen CC; Liu YT; Lin YJ; Yang YC; Chen CC; Yao HT; Chen HW; Lii CK
    Phytomedicine; 2019 Aug; 61():152841. PubMed ID: 31035043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.